[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][O][C][=C][Branch2][Ring1][#Branch1][C][=Branch1][C][=O][N][Branch1][Branch1][C][=C][Ring1][#Branch1][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][F][C][=Branch1][C][=O][N][C][=C][C][=Branch2][Ring1][#Branch1][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][=C][Branch1][#Branch2][C][=Branch1][=Branch1][=N][C][=C][Ring1][=Branch1][N][Cl][F]"}, {"from": "gpt", "value": "The molecule is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and in tumor angiogenesis."}]